Kempen Capital Management N.V. Meridian Bioscience Inc Transaction History

Kempen Capital Management N.V.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$23.75 - $31.69 $5.02 Million - $6.69 Million	-211,163 Reduced 13.67%	1,333,091 $40.6 Million
Q1 2022 May 13, 2022	BUY	$19.97 - $26.94 $3.49 Million - $4.71 Million	174,907 Added 12.77%	1,544,254 $40.1 Million
Q4 2021 Feb 11, 2022	BUY	$17.46 - $21.61 $14.3 Million - $17.7 Million	818,144 Added 148.43%	1,369,347 $27.9 Million
Q3 2021 Nov 15, 2021	BUY	$17.35 - $22.5 $2.37 Million - $3.08 Million	136,880 Added 33.04%	551,203 $10.6 Million
Q2 2021 Aug 13, 2021	BUY	$18.01 - $28.32 $7.46 Million - $11.7 Million	414,323 New	414,323 $9.19 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Kempen Capital Management N.V., based on Form 13F filings with the SEC.

Stay updated on Kempen Capital Management N.V. with notifications on news.